Navigation Links
Glycotex Reports First Patient Enrollment in Phase IIb Study of Lead Product Candidate GLYC-101 for Wound Healing
Date:10/21/2008

ROCKVILLE, Md., Oct. 20 /PRNewswire/ -- Glycotex, Inc. today announced enrollment of the first patient in a Phase IIb study evaluating the effect of GLYC-101 on wound closure and cosmetic outcomes in cosmetic surgery patients undergoing carbon dioxide laser skin resurfacing on the lower eyelid area.

A previous Phase II Pilot Study, investigating clinical outcomes and safety parameters of GLYC-101 at two doses compared to placebo was completed in April 2008.

The current randomized, double-blind, placebo-controlled clinical study will enroll approximately 48 patients at one clinical trial site in Beverly Hills, California. Patients will be randomized to receive either GLYC-101 0.1% or GLYC-101 1.0% gel on one lower eyelid, and placebo on the other lower eyelid applied topically to the laser-ablated area immediately following the laser procedure and for four consecutive days thereafter. The primary efficacy endpoint of the study is time to wound healing, and the secondary efficacy point is cosmetic outcomes, including scarring. The study will observe the effects of the topical agent over the course of one month following the initial treatment with the investigational compound and placebo.

About GLYC-101

GLYC-101 is intended to stimulate and modulate the natural cascade of wound healing activities of several cell populations. The product candidate is a topical gel to be applied directly on the wound surface. In May 2006, Glycotex completed a Phase II clinical trial of GLYC-101 in Australia, in which GLYC-101 produced a statistically significant rate of wound area reduction versus combined placebo and standard care in patients with chronic venous ulcers. The results provided proof-of concept and dose-ranging information for GLYC-101.

The strategic priorities for GLYC-101 include wound healing following laser ablation, burn wounds, surgical wounds, venous ulcers and diabetic ulcers.

About Glycotex, Inc.

Glycotex, Inc
'/>"/>

SOURCE Glycotex, Inc.
Copyright©2008 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3

Related biology technology :

1. InterMune Reports Japanese Regulatory Approval of Pirfenidone in IPF
2. PURE Bioscience Reports Fourth Quarter and Year End Results
3. Cryo-Cell International, Inc. Reports Third Quarter 2008 Results
4. Nyer Medical Group, Inc. Reports Revenues of $71.2 Million With Net Loss of $.10 Per Share for Fiscal Year 2008
5. Alfacell Reports Fiscal Fourth Quarter and Full Year 2008 Financial Results
6. Neptune Technologies & Bioressources Inc. reports first quarter results
7. CardioDynamics Reports Third Quarter 2008 Results, Seventh Consecutive Quarterly Revenue Growth and 15% Year to Date Revenue Increase
8. Paper in Cell Cycle Reports Alfacells ONCONASE(R) Targets siRNA
9. Genetic Engineering & Biotechnology News reports on growing role of molecular diagnostics
10. TorreyPines Therapeutics Reports Successful End-of-Phase II Meeting With FDA for Tezampanel
11. Corgenix Reports Fiscal 2008 Financial Results

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/19/2009)... 19 Spherix Incorporated...or diabetes therapy, and a provider of technical a...ent, biotechnology and pharmaceutical companies, a...6.3 million registered direct placement to institu... stock and warrants to purchase up to 1,104,348 ad...
(Date:11/19/2009)...- Aegera Therapeutics Inc. announced today the dos...study of AEG35156, a targeted antisense therapeuti...ndications. ,, The study, entitled "An Open-Lab...tor of Apoptosis (XIAP) Antisense AEG35156 Given i...icin in AML Following Failure of a Single Standard...
(Date:11/18/2009)...re/ -- Marrone Bio Innovations (MBI), a leader in ...f effective and environmentally responsible pest m...ed an IC20 company by the Investors, Circle, the U...vesting group. ,, Companies named to the IC20 e...or all stakeholders, including investors, the envi...
(Date:11/18/2009)...ewswire-FirstCall/ -- Sangamo BioSciences, Inc. (N...University of Pennsylvania investigator sponsored ...ease (ZFN) based product, SB-728-T, for HIV/AIDS w... internet. ,, Data were presented in a student ... Medicine from a single subject treated with SB-72...
Breaking Biology Technology:Spherix Announces the Closing of $6.3 Million Registered Direct Offering 2Spherix Announces the Closing of $6.3 Million Registered Direct Offering 3Aegera Therapeutics Initiates a Randomized Phase 2B Study with AEG35156 for the Treatment of Acute Myeloid Leukemia (AML) 2Marrone Bio Innovations Named an IC20 Company 2Sangamo BioSciences Provides Update on Phase 1 Safety Trial of SB-728-T for HIV/AIDS 2
...prove Diabetes Care, PERRYSBURG, Ohio, Feb. 25 A... the medical, humanistic and financial elements of...nal Business Coalition on,Health (NBCH). FrontPath...Lake Erie Health Quality Initiative of Perrysburg,...ncludes the City of Toledo, the University of,Tole...
...onal,Confocal Microscopy Working Group, an indepen...has been formed as a means to promote the,betterme...copy (RCM) in,patient care., The Working Group is...logists, dermascopists, dermatopathologists, medic...learning more about RCM should consider,joining th...
...nnect 170 Clinicians with ...t from the HIMSS,2008 Conference and Exhibition, A...re, connectivity and information solutions that ph...ed that CIGNA Medical Group (CMG),has selected All...ovider,for their primary care and specialty physic...
Other Biology Technology:FrontPath Health Coalition To Lead Community-wide Group in Pilot Program 2FrontPath Health Coalition To Lead Community-wide Group in Pilot Program 3International Confocal Microscopy Working Group Established to Advance Practice of Reflective Confocal Microscopy 2CIGNA Medical Group Selects Allscripts for Electronic Health Record 2CIGNA Medical Group Selects Allscripts for Electronic Health Record 3
(Date:11/19/2009)... This week, scientists are revealing the genetic i...al crops. Corn, or maize, has one of the most comp...y of Wisconsin-Madison genomicist David Schwartz, ...e in the journal Science . , "The maize genome ...-ends that have troubled would-be sequencers for y...
(Date:11/19/2009)...sive survey of genetic diversity in maize, also kn... have developed a gene map that should pave the wa... major source of food, fuel, animal feed and fiber... of gene map known as a haplotype map, charts gene...of 27 inbred lines of maize. The research team, le...
(Date:11/19/2009)...ed by Penn State,s Ross Hardison, T. Ming Chu Prof...aken a large step toward unraveling how regulatory...during development and growth. Working with collab...bel at Children,s Hospital of Philadelphia, they f...ucing red blood cells (erythrocytes). These cells ...
Breaking Biology News(10 mins):Sweet corn story begins in UW-Madison lab 2Sweet corn story begins in UW-Madison lab 3New research into the mechanisms of gene regulation 2New research into the mechanisms of gene regulation 3New research into the mechanisms of gene regulation 4New research into the mechanisms of gene regulation 5Kaiser Permanente Project Proves Electronic Health Information and Care Coordination Improve Chronic Disease Management 51241 1Kaiser Permanente Project Proves Electronic Health Information and Care Coordination Improve Chronic Disease Management 51241 2Kaiser Permanente Project Proves Electronic Health Information and Care Coordination Improve Chronic Disease Management 51241 3Kaiser Permanente Project Proves Electronic Health Information and Care Coordination Improve Chronic Disease Management 51241 4Dry Mouth Linked to Prescription and Over the Counter Drugs 4704 1Dry Mouth Linked to Prescription and Over the Counter Drugs 4704 2Dry Mouth Linked to Prescription and Over the Counter Drugs 4704 3Dry mouth linked to prescription and over the counter drugs 51232 1Dry mouth linked to prescription and over the counter drugs 51232 2Dry mouth linked to prescription and over the counter drugs 51232 3
...; however, you can find one in an article from la...a step toward making living cells function as if t...ve programmed bacteria to communicate with each ot... accomplished in a biology lab within the Departme...ant proof-of-principle in an emerging field known ...
...e of positron emission tomography (PET) and small ...he door to understanding and treating human diseas...edicine,s Journal of Nuclear Medicine. , A major b...carry out many studies at various time points with...h, Ph.D., co-author of "Preparation, Biodistributi...
...buted by invitation to an international scientific...negal, to identify strategies for the control of t...ar, locusts stripped fields of crops and trees of ...ncome and food supply loss. , Larry Vaughan, asso...ted Pest Management Collaborative Research Support...
Other Biology News:Programmable cells: Engineer turns bacteria into living computers 2Programmable cells: Engineer turns bacteria into living computers 3Use of PET can reduce, may eliminate more strenuous drug development trials with animals 2Use of PET can reduce, may eliminate more strenuous drug development trials with animals 3Use of PET can reduce, may eliminate more strenuous drug development trials with animals 4Scientists discuss improved biopesticides for locust control in West Africa 2
HSV 1 IgM ELISA Kit from Biomeda Corporation
Anti-Epstein-Barr Virus (EBV) (EBNA-1) Polyclonal Antibody, Biotin Conjugated from ViroStat Inc.
Chicken Anti-Human X box-binding protein 1 Polyclonal Antibody, Unconjugated from GenWay Biotech, Inc.
Rabbit Anti-Neuron navigator 1 Polyclonal Antibody, Unconjugated from Abcam
Biology Products: